Increased Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan Based on a Claims Database

The rate of child and adolescent patients prescribed antidepressants increased, while the antidepressant prescription rate among child and adolescent patients with MDD declined, indicating that Japanese physicians have become more cautious about the use of antidepressants. It is critical to generate new clinical data on the efficacy and safety of antidepressants for Japanese child and adolescent patients with MDD and to consider the development of additional pediatric indications for antidepressant therapy.

Authors

Institutions

Publication Details

Journal
Neuropsychiatric Disease and Treatment
Published
2025-10-01
DOI
https://doi.org/10.2147/ndt.s537251
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan Based on a Claims Database

Keita Yamauchi, Keisuke Nomoto, Ataru Inagaki
Neuropsychiatric Disease and Treatment
Bipolar Disorder and Treatment
article

Increased Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan Based on a Claims Database

Keita Yamauchi, Keisuke Nomoto, Ataru Inagaki
article en

Abstract

The rate of child and adolescent patients prescribed antidepressants increased, while the antidepressant prescription rate among child and adolescent patients with MDD declined, indicating that Japanese physicians have become more cautious about the use of antidepressants. It is critical to generate new clinical data on the efficacy and safety of antidepressants for Japanese child and adolescent patients with MDD and to consider the development of additional pediatric indications for antidepressant therapy.

Neuropsychiatric Disease and TreatmentVol. Volume 21
Aoyama Gakuin University (JP), Keio University Shonan Fujisawa (JP), Tris Pharma (United States) (US)
Meiji Seika Pharma, Shionogi, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma Corporation
Openalex Percentile: Top 64%
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.